HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category - Wikidata - awgldk - TriplyDB

HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category

HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category

http://www.wikidata.org/entity/Q34107708

about

Outcomes from unrelated donor hematopoietic stem cell transplantation Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia.Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.The use of intravenous antibiotics at the onset of neutropenia in patients receiving outpatient-based hematopoietic stem cell transplants Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS).A comparative reference study for the validation of HLA-matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units.Primary Immune Deficiency Treatment Consortium (PIDTC) report.Adoptable strategic approaches to improve outcomes of allogeneic peripheral blood stem cell transplantations from unrelated donors.Stopping higher-risk myelodysplastic syndrome in its tracks.Immunotherapy in acute myeloid leukemia.Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI.Reduced BUCY 2 and G-CSF-primed bone marrow associates with low graft-versus-host-disease and transplant-related mortality in allogeneic HSCT.Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors.Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial.Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation.

P2860

Q27027854-897CF9C6-8179-4915-9C21-71AAB125EB48 Q28080943-CC66D0DB-F42B-45FC-A969-7D1F3F400D93 Q33830964-8FA5E5F4-BB03-49AB-AC2C-C58D7E512A6F Q35953348-9E4647C0-531F-47C8-91EA-CC3FA62E4046 Q36040293-21509FD7-28E6-40C2-88B1-D70B39B343C3 Q36287292-26BBFF0F-EB81-4CEB-90DF-F76C7F15D9F6 Q36812102-562DD5AD-2085-4F4F-850E-AEE674008903 Q36822659-C6E75E38-19D4-4CA1-AF34-CAD93C4C36F7 Q36980277-0CA93B04-5404-4819-89F3-256B215FA9F9 Q37169115-2F7B09A6-A536-4613-A169-A0EC2631F420 Q37384843-036340C8-40BD-425D-B75F-6B16BD78A1A9 Q37649782-ACB34E75-FBAB-4B22-B82D-87603D8BB97C Q38164819-87C985E3-7D2B-494E-B3A0-16F270A1588E Q38248180-8F9BBD68-FB5D-45F7-BACD-56EB58189626 Q38533606-1047A023-2723-4089-8FDE-4CD9C4CC2E7E Q40049548-62ADE10B-8B4D-4C25-906E-9B1EBE0AF8B1 Q40129891-7281B880-8016-4F95-8306-357FFE7E5674 Q41525058-EB3F2DA1-FF67-4779-B9B7-8CA042E0513F Q44571503-F5F5B99F-A012-4E12-A778-D00DDCF8A99C Q51031888-B269F6C6-EC6B-404D-8D1C-66BE04E56CEC Q53761924-992678FE-A84E-4827-A8C6-D705AE6258B5

P2860

HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category

http://www.wikidata.org/entity/Q34107708

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

HLA-allele matched unrelated d ...... urce and disease risk category

@ast

HLA-allele matched unrelated d ...... urce and disease risk category

@en

HLA-allele matched unrelated d ...... urce and disease risk category

@nl

type

label

HLA-allele matched unrelated d ...... urce and disease risk category

@ast

HLA-allele matched unrelated d ...... urce and disease risk category

@en

HLA-allele matched unrelated d ...... urce and disease risk category

@nl

prefLabel

HLA-allele matched unrelated d ...... urce and disease risk category

@ast

HLA-allele matched unrelated d ...... urce and disease risk category

@en

HLA-allele matched unrelated d ...... urce and disease risk category

@nl

P1433

Q34107708-955FB06B-B30D-4554-9509-9E4672296B8B

P1476

Q34107708-8309D182-0255-41C1-8DF6-8C322482A1AA

P2093

Q34107708-31758B6D-26B5-4284-8580-956841A6C8D8

Q34107708-406D90DD-A3B7-44F1-A8C3-82260A521FF8

Q34107708-785D9E62-815C-4E98-88AE-7D0E7BC89CDB

Q34107708-8ED8A921-7F51-497D-B15D-5625E1710816

Q34107708-9C933D11-CA5F-4745-B8A5-63EA74100E60

Q34107708-C7E84C67-F8A7-4ABE-81F0-ED812CA96142

Q34107708-D71300BA-1934-40A8-A925-08D8EC993B6B

P2860

Q34107708-027CF009-FB28-4152-BA66-DF2AA14CE58F

Q34107708-0D8BC1AE-C8E1-4B5F-BEF7-B9864FA5D19A

Q34107708-2740F5AC-8D74-451E-A65C-A23A695E316E

Q34107708-6C0732F4-22DA-41F3-9E72-828EAD056819

Q34107708-88DE9C9F-C218-4050-9DE4-781383830BAB

Q34107708-E5E1CC88-8DAD-4BE0-A76B-60569D595C16

Q34107708-F92D9306-90EF-4696-B649-E429682D6BD0

P304

Q34107708-74B34662-E13E-401E-951F-92158F912DCB

P31

Q34107708-622A8177-7A0E-4CB4-9CBA-B31675D8404C

P356

Q34107708-DBBE22C0-E303-48E0-9EF7-56004965B38B

P433

Q34107708-256C01FE-9F71-43A4-A2FC-B95287F11570

P478

Q34107708-18756EE7-4E22-45AC-AFD3-B3FE460087A1

P50

Q34107708-CC09E48C-D246-418D-801F-77DBC50245BB

P577

Q34107708-9E7FC912-7E4A-41C0-A233-DAE6C7491721

P5875

Q34107708-9692BC15-138B-48FF-9E0D-7E181A2DE52E

P698

Q34107708-E5C862E8-A7D9-41B9-A69B-FA3E8A4B5A5F

P921

Q34107708-B729257F-4940-43DB-8A71-2FFC1AB2081E

P932

Q34107708-C8C2A291-2C03-4CE6-B97C-F8807AE9B968

P356

J.BBMT.2010.03.024

P1433

Biology of Blood and Marrow Transplantation

P1476

HLA-allele matched unrelated d ...... urce and disease risk category

@en

P2093

Ann Woolfrey

http://www.w3.org/2001/XMLSchema#string

Effie Petersdorf

http://www.w3.org/2001/XMLSchema#string

John A Hansen

http://www.w3.org/2001/XMLSchema#string

John M Pagel

http://www.w3.org/2001/XMLSchema#string

Mari Malkki

http://www.w3.org/2001/XMLSchema#string

Paul J Martin

http://www.w3.org/2001/XMLSchema#string

Ted A Gooley

http://www.w3.org/2001/XMLSchema#string

P2860

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Part

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group.

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.

Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain.

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

P304

1382-1387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2010.03.024

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Stephanie J Lee

P577

2010-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44577927

http://www.w3.org/2001/XMLSchema#string

P698

20447462

http://www.w3.org/2001/XMLSchema#string

P921

P932

2934755

http://www.w3.org/2001/XMLSchema#string